A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
+1 (978) 421-9655
ZOLL Medical Corporation
+1 (978) 421-9637
FOR IMMEDIATE RELEASE
ZOLL Medical Displays Leading Resuscitation Products at 2006 EMS Today
Guidelines-Compliant Real CPR Help Technology On Display
March 21, 2006—CHELMSFORD, MASS.—ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices and related software solutions, will display a range of its products at the 2006 EMS Today Exposition on March 24 and March 25 at the Baltimore Convention Center. These offerings help EMS professionals comply with and support new 2005 American Heart Association (AHA) Guidelines, including performing high-quality CPR.
“When ZOLL offered Real CPR Help™ technology in the AED Plus™ in 2002, we were the first manufacturer at the time to recognize the importance of helping rescuers with CPR performance,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “This approach was validated by the strong emphasis on CPR in the 2005 AHA Guidelines. To date, ZOLL estimates that 500,000 rescuers have access to ZOLL AEDs that can help them perform high-quality CPR. We will continue our commitment to offer such novel technologies that help lay rescuers and healthcare professionals provide high-quality CPR and improve their resuscitation efforts so that more people survive cardiac arrest.”
ZOLL offers a system of products that helps EMS professionals with a range of resuscitation issues: Defibrillation, circulation, electronic documentation, and information management. When customers use its products together, ZOLL believes they can realize improvements that help them operate more efficiently.
ZOLL Resuscitation Products on Display at 2006 EMS Today
ZOLL’s AED Plus and AED Pro® offer Real CPR Help through the use a special electrode, known as the CPR-D•padz™, which includes a sensor that measures the rate and depth of chest compressions. This Real CPR Help functionality offers rescuers instantaneous feedback on the rate and depth of chest compressions. In addition, the AED Pro supports the AHA recommendations of a universal compression-to-ventilation ratio of 30:2 for single rescuers. The AED Pro also includes configurable options for use by either BLS or ALS systems using airway devices.
The ZOLL AutoPulse® Non-invasive Cardiac Support Pump—the only device of its kind—delivers the consistent, uninterrupted chest compressions that the 2005 AHA Guidelines call for. The news Guidelines note that load-distributing band CPR “may be considered for use by trained personnel as an adjunct to CPR for patients in cardiac arrest (Class llb).”* It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest, improving blood flow to the heart and brain during cardiac arrest.* Additionally, it can help free up rescuers to focus on other life-saving interventions and eliminate rescuer fatigue from the performance of CPR chest compressions. Recent study results demonstrate that the AutoPulse has contributed to improvements in long-term and short-term survival rates.*
The rugged ZOLL E Series™ is designed to meet the specific demands and extreme conditions that professional rescuers face every day. Manual operation of the E Series for ACLS users is currently Guidelines compliant. Its EasyRead Tri-Mode Display™, for use in pitch dark or direct sunlight, provides superior readability and complete views of critical patient information from virtually any angle. Its suitcase-style design and protective roll cage, allow personnel to carry and store the device more easily. In addition, optional Bluetooth® functionality can provide data transmission capability to a variety of destinations, including transmission of 12-lead ECGs, which AHA Guidelines recommend for out-of-hospital use to help reduce time to perfusion in acute myocardial infarction.*
RescueNet™, from ZOLL Data Systems™, is a suite of integrated EMS software applications that allows users to electronically capture, collect, and review a range of data not only for improving JCAHO compliance, but also for evaluating resuscitation performance and reviewing outcomes, which can support ongoing quality improvement.
The ZOLL M Series® family of defibrillators has been selected as the standard of care in leading EMS and healthcare facilities around the world. ZOLL was the first company to have plug-and-play mainstream and sidestream EtCO2 monitoring options. The M Series combines the clinical superiority of ZOLL’s Rectilinear Biphasic™ waveform with portability, ease-of-use, and a vivid screen display. In addition, M Series defibrillators use ZOLL’s patented pacing technology, which has been clinically shown to offer superior capture rates, provide lower mean capture thresholds, and allow better patient tolerance to external pacing. The M Series CCT is designed specifically for critical care transport needs and is certified airworthy for military applications.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East, Asia, and Australia. For more information, visit www.zoll.com or call +1 (978) 421-9655.
Certain statements contained in this press release regarding matters that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL’s ability to compete; acceptance of its resuscitation products; changes in regulations affecting the healthcare industry; general economic conditions; and those other factors discussed in the section entitled “Risk Factors” in ZOLL’s Quarterly Report on Form 10-Q, which was filed with the SEC on February 10, 2006.
© 2006 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AED Plus, CPR-D•padz, E Series, Easy Read Tri-Mode Display, Real CPR Help, Rectilinear Biphasic, RescueNet, and ZOLL Data Systems are trademarks of ZOLL Medical Corporation. AED Pro, AutoPulse, LifeBand, M Series, and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.
*Clinical data and citations available upon request.